SLS
Sellas Life Sciences Group Inc
11.70$
+3.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | +22.0% | +274.7% | -100.0% | – | – | – | – | – | +399,900.0% | -86.8% | -100.0% | – | – | |
| – | – | – | – | – | – | -69.9% | +961.2% | +169.8% | -74.7% | -99.2% | -100.0% | – | – | – | -46.9% | -50.0% | -100.0% | – | – | |
| – | – | – | – | – | – | – | -3.5% | +302.4% | -104.5% | – | – | – | – | – | +389,373.7% | -87.8% | -100.0% | – | – | |
| – | +419.8% | +4.6% | +26.1% | -11.5% | +46.6% | +26.7% | +44.2% | +34.5% | -16.7% | -15.9% | -69.5% | +201.9% | -44.8% | -8.3% | +130.3% | +41.6% | -20.7% | -20.5% | -16.1% | |
| – | – | +30.5% | +12.5% | +59.6% | -21.6% | -4.1% | +121.7% | +114.7% | -66.2% | +13.2% | +25.7% | -15.4% | -22.3% | -3.3% | +17.9% | +11.1% | +10.2% | -10.4% | -1.3% | |
| – | +374.6% | +27.5% | +20.4% | -6.1% | +26.3% | +2.0% | +68.9% | +68.0% | -43.7% | -5.9% | -33.6% | +49.3% | -36.6% | -194.2% | – | +31.1% | -11.6% | -16.8% | -10.3% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | +0.0% | -100.0% | – | +2,345.5% | +37.5% | -31.5% | +361.6% | -86.8% | -42.4% | -55.6% | +230.5% | +1,017.4% | -85.1% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | -634.3% | – | – | – | -1,568.3% | – | -33.4% | +4.1% | -644.7% | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | -579.9% | – | – | – | – | – | +3,870.7% | -169.1% | – | – | +19.5% | -4,350.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.